• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氮杂肽及其治疗潜力。

Azapeptides and their therapeutic potential.

机构信息

Département de Chimie, Université de Montréal, CP 6128, Succursale Centre Ville, Montréal, Québec, H3C3J7, Canada.

出版信息

Future Med Chem. 2011 Jul;3(9):1139-64. doi: 10.4155/fmc.11.74.

DOI:10.4155/fmc.11.74
PMID:21806378
Abstract

Azapeptides are peptide analogs in which one or more of the amino residues is replaced by a semicarbazide. This substitution of a nitrogen for the α-carbon center results in conformational restrictions, which bend the peptide about the aza-amino acid residue away from a linear geometry. The resulting azapeptide turn conformations have been observed by x-ray crystallography and spectroscopy, as well as predicted based on computational models. In biologically active peptide analogs, the aza-substitution has led to enhanced activity and selectivity as well as improved properties, such as prolonged duration of action and metabolic stability. In light of these characteristics, azapeptides have found important uses as receptor ligands, enzyme inhibitors, drugs, pro-drugs, probes and imaging agents. Recent improvements in synthetic methods for their procurement have ushered in a new era of azapeptide chemistry. This review aims to provide a historical look at the development of azapeptide science along with a focus on recent developments and perspectives on the future of this useful tool for medicinal chemistry.

摘要

氮杂肽是一种肽类似物,其中一个或多个氨基酸残基被氨基脒取代。这种氮原子取代α-碳中心导致构象受限,使肽围绕氮杂氨基酸残基弯曲,偏离线性几何形状。通过 X 射线晶体学和光谱学观察到了氮杂肽的构象,也可以根据计算模型进行预测。在具有生物活性的肽类似物中,氮杂取代导致活性和选择性增强,以及改善了性质,如作用持续时间延长和代谢稳定性提高。鉴于这些特性,氮杂肽已被广泛用作受体配体、酶抑制剂、药物、前药、探针和成像剂。其采购的合成方法的最新改进开创了氮杂肽化学的新时代。本文旨在回顾氮杂肽科学的发展,并重点介绍最近的进展和对这一有用的药物化学工具的未来展望。

相似文献

1
Azapeptides and their therapeutic potential.氮杂肽及其治疗潜力。
Future Med Chem. 2011 Jul;3(9):1139-64. doi: 10.4155/fmc.11.74.
2
Azapeptide Synthesis Methods for Expanding Side-Chain Diversity for Biomedical Applications.用于扩展生物医学应用中侧链多样性的氮杂肽合成方法。
Acc Chem Res. 2017 Jul 18;50(7):1541-1556. doi: 10.1021/acs.accounts.7b00114. Epub 2017 Jun 9.
3
Synthesis and properties of the first all-aza analogue of a biologically active peptide.一种生物活性肽的首个全氮类似物的合成与性质
J Pept Sci. 1995 May-Jun;1(3):201-6. doi: 10.1002/psc.310010307.
4
Aza-amino acid scan for rapid identification of secondary structure based on the application of N-Boc-aza(1)-dipeptides in peptide synthesis.基于N-Boc-氮杂(1)-二肽在肽合成中的应用的氮杂氨基酸扫描用于快速鉴定二级结构。
J Am Chem Soc. 2004 Jun 2;126(21):6759-64. doi: 10.1021/ja039643f.
5
Novel azapeptide inhibitors of hepatitis C virus serine protease.新型丙型肝炎病毒丝氨酸蛋白酶的氮杂肽抑制剂。
J Med Chem. 2004 Jul 15;47(15):3788-99. doi: 10.1021/jm049864b.
6
Azapeptides: a new class of angiotensin-converting enzyme inhibitors.
Biochem Biophys Res Commun. 1984 Jul 31;122(2):791-7. doi: 10.1016/s0006-291x(84)80103-5.
7
Design of selective peptidomimetic agonists for the human orphan receptor BRS-3.人孤儿受体BRS-3选择性拟肽激动剂的设计
J Med Chem. 2003 May 8;46(10):1918-30. doi: 10.1021/jm0210921.
8
Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.强效促黑素皮质素受体激动剂Ac-His-D-Phe-Arg-Trp-NH的氮杂扫描
Chem Biol Drug Des. 2006 Apr;67(4):275-83. doi: 10.1111/j.1747-0285.2006.00378.x.
9
Azapeptides as pharmacological agents.氮杂肽作为药物制剂。
Curr Med Chem. 2005;12(5):589-97. doi: 10.2174/0929867310504050589.
10
Novel aza peptide inhibitors and active-site probes of papain-family cysteine proteases.木瓜蛋白酶家族半胱氨酸蛋白酶的新型氮杂肽抑制剂及活性位点探针
Chembiochem. 2006 Jun;7(6):943-50. doi: 10.1002/cbic.200600001.

引用本文的文献

1
Design, Synthesis, and Evaluation of Aza-Peptide Michael Acceptors as Human 20S Proteasome Inhibitors: Extension to the Prime Site.氮杂肽迈克尔受体作为人20S蛋白酶体抑制剂的设计、合成与评价:向活性中心的拓展
ACS Omega. 2025 Jul 16;10(29):31549-31567. doi: 10.1021/acsomega.5c02128. eCollection 2025 Jul 29.
2
Azapeptide Atropisomers From Late-Stage -Alkylations.后期烷基化反应生成的氮杂肽阻转异构体
J Org Chem. 2025 Jul 11;90(27):9549-9558. doi: 10.1021/acs.joc.5c01024. Epub 2025 Jun 30.
3
Metallo-azapeptides: Controlled Metal Chelation to Peptide Backbone Nitrogen.
金属氮杂肽:肽主链氮的可控金属螯合作用
J Am Chem Soc. 2025 Jan 15;147(2):1404-1410. doi: 10.1021/jacs.4c14536. Epub 2025 Jan 6.
4
Influence of Aza-Glycine Substitution on the Internalization of Penetratin.氮杂甘氨酸取代对穿膜肽内化作用的影响。
Pharmaceutics. 2024 Mar 30;16(4):477. doi: 10.3390/pharmaceutics16040477.
5
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors.具有独特共价弹头的氮杂肽作为 SARS-CoV-2 主蛋白酶抑制剂。
Antiviral Res. 2024 May;225:105874. doi: 10.1016/j.antiviral.2024.105874. Epub 2024 Mar 28.
6
P Glutamine isosteres in the design of inhibitors of 3C/3CL protease of human viruses of the class.人γ冠状病毒3C/3CL蛋白酶抑制剂设计中的P谷氨酰胺等排体
RSC Chem Biol. 2023 Jun 21;4(8):533-547. doi: 10.1039/d3cb00075c. eCollection 2023 Aug 3.
7
Cyclic Peptides in Pipeline: What Future for These Great Molecules?处于研发阶段的环肽:这些伟大分子的未来如何?
Pharmaceuticals (Basel). 2023 Jul 12;16(7):996. doi: 10.3390/ph16070996.
8
Unnatural helical peptidic foldamers as protein segment mimics.非天然螺旋肽折叠作为蛋白质片段模拟物。
Chem Soc Rev. 2023 Jul 31;52(15):4843-4877. doi: 10.1039/d2cs00395c.
9
A lysine-based 2:1-[α/aza]-pseudopeptide series used as additives in polymeric membranes for CO capture: synthesis, structural studies, and application.一种基于赖氨酸的2:1-[α/氮杂]-拟肽系列,用作聚合物膜中CO捕获的添加剂:合成、结构研究及应用。
RSC Adv. 2023 Mar 29;13(15):10051-10067. doi: 10.1039/d3ra00409k. eCollection 2023 Mar 27.
10
Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates.硫代卡巴腙结构单元可用于构建氮杂肽,以快速开发治疗候选药物。
Nat Commun. 2022 Nov 28;13(1):7127. doi: 10.1038/s41467-022-34712-9.